ENDRA Life Sciences (NDRA)
4.86
-0.37 (7.07%)
Upcoming Events
Latest Headlines
Form 425 ENDRA Life Sciences Inc. Filed by: ASP Isotopes Inc.
July 22, 2026 8:36 AM - SEC Filing
Form 425 ENDRA Life Sciences Inc. Filed by: ASP Isotopes Inc.
July 22, 2026 6:05 AM - SEC Filing
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company
July 17, 2026 10:35 AM - BizWire
Form 425 ENDRA Life Sciences Inc. Filed by: ASP Isotopes Inc.
July 17, 2026 8:21 AM - SEC Filing
Form 425 ENDRA Life Sciences Inc. Filed by: ENDRA Life Sciences Inc.
July 17, 2026 8:20 AM - SEC Filing
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company
July 17, 2026 8:00 AM - StreetInsider
Form 8-K ENDRA Life Sciences Inc. For: Jul 08
July 9, 2026 6:09 AM - SEC Filing
Form SCHEDULE 13D/A ENDRA Life Sciences Inc. Filed by: DIGIANDOMENICO ANTHONY
June 29, 2026 9:30 PM - SEC Filing
Form 425 ENDRA Life Sciences Inc. Filed by: ENDRA Life Sciences Inc.
June 26, 2026 6:17 AM - SEC Filing
Form 8-K ENDRA Life Sciences Inc. For: Jun 25
June 26, 2026 6:11 AM - SEC Filing
Form 144 ENDRA Life Sciences Inc. Filed by: DIGIANDOMENICO ANTHONY
June 25, 2026 6:25 PM - SEC Filing
Form 425 ENDRA Life Sciences Inc. Filed by: ASP Isotopes Inc.
June 25, 2026 5:26 PM - SEC Filing
Form 425 ENDRA Life Sciences Inc. Filed by: ENDRA Life Sciences Inc.
June 25, 2026 9:39 AM - SEC Filing
Form 8-K ENDRA Life Sciences Inc. For: Jun 25
June 25, 2026 9:37 AM - SEC Filing
ASP Isotopes unit to merge with ENDRA Life Sciences in $50M deal
June 25, 2026 9:30 AM - StreetInsider
ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing
June 25, 2026 9:30 AM - StreetInsider
Form 8-K ENDRA Life Sciences Inc. For: May 27
May 28, 2026 6:08 AM - SEC Filing
Form RW ENDRA Life Sciences Inc.
May 26, 2026 5:00 PM - SEC Filing
ENDRA Life Sciences (NDRA) Misses Q1 EPS by 109c
May 18, 2026 8:24 AM - StreetInsider
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
May 18, 2026 8:00 AM - BizWire
Form S-8 ENDRA Life Sciences Inc.
May 15, 2026 4:20 PM - SEC Filing
Form 10-Q ENDRA Life Sciences Inc. For: Mar 31
May 15, 2026 4:03 PM - SEC Filing
ENDRA Life Sciences reports liver device validation results
May 14, 2026 8:01 AM - StreetInsider
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility
May 14, 2026 8:00 AM - BizWire
Full Article List